• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液生物标志物对接受脑室腹腔分流术的特发性正常压力脑积水患者的神经认知影响。

Neurocognitive effects of CSF biomarkers in idiopathic normal pressure hydrocephalus patients undergoing VP shunt placement.

作者信息

Spielmann Hannah, Lepshokov Magomed, Prajsnar-Borak Anna, Wagenpfeil Gudrun, Oertel Joachim

机构信息

Klinik für Neurochirurgie, Medizinische Fakultät, Universität des Saarlandes, Homburg, Saar, Germany.

Klinik für Neurochirurgie, Landeskrankenhaus Feldkirch, Feldkirch, Österreich.

出版信息

Neurosurg Rev. 2025 Jun 5;48(1):484. doi: 10.1007/s10143-025-03609-8.

DOI:10.1007/s10143-025-03609-8
PMID:40471348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141128/
Abstract

Idiopathic normal pressure hydrocephalus is an increasingly prevalent neurodegenerative condition among the elderly, characterized by the Hakim triad. Accurate diagnosis and prognosis are essential since the symptoms can be reversible with appropriate treatment, such as VP-shunt surgery. This study investigates the relationship between cerebrospinal fluid biomarkers, particularly Tau, Phospho-tau, the beta-amyloid ratio (Aβ42/Aβ40), and neurocognitive outcomes post-surgery. Eighty patients diagnosed with iNPH who underwent shunt placement between November 2021 and July 2023 were included. A comprehensive neuropsychological test battery was administered before, one hour after, and one day after lumbar puncture, and six weeks and three months post-surgery. CSF samples were analyzed for tau, phospho-tau and the beta-amyloid ratio. Neuropsychological tests assessed various cognitive functions, including executive functions, psychomotor speed, language, and memory. Patients with a higher beta-amyloid ratio showed significant cognitive improvement post-surgery. Neuropsychological tests, such as the DemTect and Trail Making Test A & B indicated enhanced performance over time, particularly at the three-month follow-up. Conversely, the MMSE did not show significant improvement. The data suggest that the beta-amyloid ratio is a potential prognostic marker for positive neurocognitive outcomes following VP-shunt surgery. The beta-amyloid ratio (Aß42/Aß40) may represent a valuable prognostic biomarker for predicting cognitive improvement after VP-shunt surgery. Patients with higher ratios exhibited better neurocognitive outcomes, emphasizing the importance of comprehensive neuropsychological assessments. These findings support the potential of personalized treatment strategies based on biomarker analysis to optimize patient selection and improve outcomes for iNPH patients undergoing VP-shunt surgery.

摘要

特发性正常压力脑积水是老年人中一种日益普遍的神经退行性疾病,其特征为哈基姆三联征。由于症状在适当治疗(如脑室腹腔分流术)后可逆转,因此准确诊断和预后评估至关重要。本研究调查了脑脊液生物标志物,特别是 Tau、磷酸化 Tau、β-淀粉样蛋白比率(Aβ42/Aβ40)与术后神经认知结果之间的关系。纳入了 2021 年 11 月至 2023 年 7 月期间接受分流置管的 80 例诊断为特发性正常压力脑积水的患者。在腰椎穿刺前、穿刺后 1 小时、穿刺后 1 天、术后 6 周和 3 个月进行了全面的神经心理测试。对脑脊液样本进行 Tau、磷酸化 Tau 和 β-淀粉样蛋白比率分析。神经心理测试评估了各种认知功能,包括执行功能、精神运动速度、语言和记忆。β-淀粉样蛋白比率较高的患者术后显示出显著的认知改善。DemTect 和连线测验 A&B 等神经心理测试表明,随着时间的推移,表现有所改善,尤其是在 3 个月的随访中。相反,简易精神状态检查表(MMSE)没有显示出显著改善。数据表明,β-淀粉样蛋白比率是脑室腹腔分流术后神经认知结果呈阳性的潜在预后标志物。β-淀粉样蛋白比率(Aβ42/Aβ40)可能是预测脑室腹腔分流术后认知改善的有价值的预后生物标志物。比率较高的患者表现出更好的神经认知结果,强调了全面神经心理评估的重要性。这些发现支持了基于生物标志物分析的个性化治疗策略的潜力,以优化患者选择并改善接受脑室腹腔分流术的特发性正常压力脑积水患者的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225a/12141128/0619d945f994/10143_2025_3609_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225a/12141128/0619d945f994/10143_2025_3609_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225a/12141128/0619d945f994/10143_2025_3609_Fig1_HTML.jpg

相似文献

1
Neurocognitive effects of CSF biomarkers in idiopathic normal pressure hydrocephalus patients undergoing VP shunt placement.脑脊液生物标志物对接受脑室腹腔分流术的特发性正常压力脑积水患者的神经认知影响。
Neurosurg Rev. 2025 Jun 5;48(1):484. doi: 10.1007/s10143-025-03609-8.
2
Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery.特发性正常压力脑积水:脑脊液生物标志物、临床症状与分流手术后结局之间的关联
Fluids Barriers CNS. 2025 May 19;22(1):51. doi: 10.1186/s12987-025-00661-w.
3
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水神经退行性生物标志物的脑脊液时间趋势。
J Alzheimers Dis. 2021;80(4):1629-1642. doi: 10.3233/JAD-201361.
4
The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.T-tau和AB1-42水平在特发性正常压力脑积水患者中的预测价值。
Acta Neurochir (Wien). 2017 Dec;159(12):2293-2300. doi: 10.1007/s00701-017-3314-x. Epub 2017 Sep 9.
5
Brain tissue Aβ42 levels are linked to shunt response in idiopathic normal pressure hydrocephalus.脑内 Aβ42 水平与特发性正常压力脑积水分流反应相关。
J Neurosurg. 2019 Jan 1;130(1):121-129. doi: 10.3171/2017.7.JNS171005. Epub 2018 Jan 19.
6
Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.术前脑脊液中磷酸化 tau 浓度可预测特发性正常压力脑积水患者分流术后 3 年的认知功能。
J Alzheimers Dis. 2018;66(1):319-331. doi: 10.3233/JAD-180557.
7
Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.脑脊髓液中神经丝轻链和总 tau 水平升高与正常压力脑积水患者分流手术后不良结局相关。
Fluids Barriers CNS. 2022 Feb 14;19(1):15. doi: 10.1186/s12987-022-00306-2.
8
Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.脑脊髓液和静脉生物标志物对分流反应性特发性正常压力脑积水的诊断价值:系统评价和荟萃分析。
Acta Neurochir (Wien). 2022 Jul;164(7):1719-1746. doi: 10.1007/s00701-022-05154-5. Epub 2022 Mar 1.
9
Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.反映特发性正常压力脑积水患者临床症状的脑脊液生物标志物。
Fluids Barriers CNS. 2022 Feb 5;19(1):11. doi: 10.1186/s12987-022-00309-z.
10
Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水患者阿尔茨海默病脑脊液生物标志物的两点动态观察。
J Alzheimers Dis. 2019;72(1):271-277. doi: 10.3233/JAD-190775.

本文引用的文献

1
Diagnostic and Prognostic Biomarkers of Idiopathic Normal Pressure Hydrocephalus in Cerebrospinal Fluid and Blood.脑脊液和血液中特发性正常压力脑积水的诊断和预后生物标志物
Neurosurg Clin N Am. 2025 Apr;36(2):207-231. doi: 10.1016/j.nec.2024.11.008. Epub 2025 Feb 5.
2
Predicting the long-term course: Shunt surgery results in idiopathic normal pressure hydrocephalus-a comprehensive study.预测长期病程:分流手术治疗特发性正常压力脑积水的综合研究。
Acta Neurochir (Wien). 2024 Oct 26;166(1):424. doi: 10.1007/s00701-024-06303-8.
3
In Vivo Prevalence of Beta-Amyloid Pathology and Alzheimer's Disease Co-Pathology in Idiopathic Normal-Pressure Hydrocephalus-Association with Neuropsychological Features.
特发性正常压力脑积水患者中β-淀粉样蛋白病理及阿尔茨海默病共病理的体内患病率——与神经心理学特征的关联
Biomedicines. 2024 Aug 20;12(8):1898. doi: 10.3390/biomedicines12081898.
4
Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus.特发性正常压力脑积水患者分流术后脑室 CSF 生物标志物与预后的关系。
Fluids Barriers CNS. 2023 Oct 25;20(1):77. doi: 10.1186/s12987-023-00475-8.
5
CSF Biomarkers Predict Gait Outcomes in Idiopathic Normal Pressure Hydrocephalus.脑脊液生物标志物可预测特发性正常压力脑积水的步态结局。
Neurol Clin Pract. 2022 Apr;12(2):91-101. doi: 10.1212/CPJ.0000000000001156.
6
Motor skills, cognitive impairment, and quality of life in normal pressure hydrocephalus: early effects of shunt placement.正常压力脑积水患者的运动技能、认知障碍和生活质量:分流术的早期效果。
Acta Neurochir (Wien). 2022 Jul;164(7):1765-1775. doi: 10.1007/s00701-022-05149-2. Epub 2022 Feb 25.
7
Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.反映特发性正常压力脑积水患者临床症状的脑脊液生物标志物。
Fluids Barriers CNS. 2022 Feb 5;19(1):11. doi: 10.1186/s12987-022-00309-z.
8
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review.阿尔茨海默病中抗β淀粉样肽治疗策略的过去、现在和未来:系统评价。
Ageing Res Rev. 2021 Dec;72:101496. doi: 10.1016/j.arr.2021.101496. Epub 2021 Oct 21.
9
Biomarkers for neurodegenerative diseases.神经退行性疾病的生物标志物。
Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.
10
Comprehensive Review on Alzheimer's Disease: Causes and Treatment.阿尔茨海默病的综合综述:病因与治疗。
Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.